Skandinaviska Enskilda Banken AB publ Has $19.81 Million Stake in CME Group Inc. $CME

Skandinaviska Enskilda Banken AB publ trimmed its holdings in shares of CME Group Inc. (NASDAQ:CME) by 3.9% in the third quarter, HoldingsChannel reports. The institutional investor owned 73,268 shares of the financial services provider’s stock after selling 2,971 shares during the quarter. Skandinaviska Enskilda Banken AB publ’s holdings in CME Group were worth $19,806,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. Jessup Wealth Management Inc lifted its stake in shares of CME Group by 0.5% in the 2nd quarter. Jessup Wealth Management Inc now owns 7,969 shares of the financial services provider’s stock valued at $2,197,000 after purchasing an additional 36 shares during the period. First Horizon Advisors Inc. increased its holdings in CME Group by 0.7% in the second quarter. First Horizon Advisors Inc. now owns 5,269 shares of the financial services provider’s stock valued at $1,453,000 after purchasing an additional 36 shares during the last quarter. MBM Wealth Consultants LLC lifted its stake in CME Group by 2.7% in the second quarter. MBM Wealth Consultants LLC now owns 1,422 shares of the financial services provider’s stock valued at $392,000 after buying an additional 37 shares during the period. Whittier Trust Co. of Nevada Inc. boosted its holdings in CME Group by 0.8% during the second quarter. Whittier Trust Co. of Nevada Inc. now owns 5,021 shares of the financial services provider’s stock worth $1,384,000 after buying an additional 38 shares during the last quarter. Finally, Atlatl Advisers LLC grew its position in shares of CME Group by 1.8% during the 3rd quarter. Atlatl Advisers LLC now owns 2,126 shares of the financial services provider’s stock worth $574,000 after buying an additional 38 shares during the period. 87.75% of the stock is owned by institutional investors.

Insider Buying and Selling

In other CME Group news, CEO Terrence A. Duffy sold 25,000 shares of CME Group stock in a transaction on Thursday, December 11th. The shares were sold at an average price of $269.55, for a total value of $6,738,750.00. Following the sale, the chief executive officer directly owned 65,804 shares in the company, valued at approximately $17,737,468.20. The trade was a 27.53% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director William R. Shepard acquired 251 shares of CME Group stock in a transaction dated Tuesday, December 30th. The shares were acquired at an average price of $278.37 per share, with a total value of $69,870.87. Following the completion of the purchase, the director owned 258,710 shares in the company, valued at approximately $72,017,102.70. The trade was a 0.10% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. 0.30% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

A number of brokerages recently weighed in on CME. The Goldman Sachs Group increased their price target on shares of CME Group from $264.00 to $266.00 and gave the company a “sell” rating in a research report on Monday, February 9th. Piper Sandler increased their target price on shares of CME Group from $296.00 to $313.00 and gave the stock an “overweight” rating in a report on Thursday, November 13th. Morgan Stanley lifted their price target on shares of CME Group from $319.00 to $340.00 and gave the stock an “overweight” rating in a research report on Thursday, February 5th. Deutsche Bank Aktiengesellschaft upped their price objective on shares of CME Group from $312.00 to $316.00 and gave the company a “buy” rating in a research report on Thursday, February 5th. Finally, Rothschild & Co Redburn lifted their target price on CME Group from $300.00 to $333.00 and gave the stock a “neutral” rating in a report on Thursday, February 12th. Nine analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have assigned a Sell rating to the stock. According to data from MarketBeat, CME Group presently has an average rating of “Hold” and an average price target of $299.53.

CME Group Price Performance

CME stock opened at $303.23 on Wednesday. The stock has a 50-day moving average price of $281.14 and a two-hundred day moving average price of $274.30. CME Group Inc. has a 1 year low of $244.43 and a 1 year high of $309.35. The stock has a market cap of $109.34 billion, a PE ratio of 27.17, a price-to-earnings-growth ratio of 3.29 and a beta of 0.27. The company has a current ratio of 1.03, a quick ratio of 1.02 and a debt-to-equity ratio of 0.12.

CME Group (NASDAQ:CME) last issued its quarterly earnings results on Wednesday, February 4th. The financial services provider reported $2.77 EPS for the quarter, beating analysts’ consensus estimates of $2.75 by $0.02. The company had revenue of $1.65 billion for the quarter, compared to analyst estimates of $1.64 billion. CME Group had a return on equity of 14.65% and a net margin of 62.45%.The company’s quarterly revenue was up 8.1% compared to the same quarter last year. During the same period in the previous year, the company posted $2.52 earnings per share. Equities analysts forecast that CME Group Inc. will post 10.49 EPS for the current fiscal year.

CME Group Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, March 26th. Stockholders of record on Tuesday, March 10th will be given a $1.30 dividend. This is a boost from CME Group’s previous quarterly dividend of $1.25. This represents a $5.20 dividend on an annualized basis and a dividend yield of 1.7%. The ex-dividend date of this dividend is Tuesday, March 10th. CME Group’s payout ratio is presently 46.59%.

CME Group Company Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.